Detection of cancer/testis antigens as a diagnostic tool in routine pathology practice

被引：2
作者：
Chen, Yao-Tseng [1 ]
机构：
[1] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA
来源：
ONCOIMMUNOLOGY | 2014年 / 3卷 / 02期
关键词：
tumor antigens; immunohistochemistry; biomarker; sarcoma; diagnostic pathology; NY-ESO-1; EXPRESSION; CELL; LIPOSARCOMAS; SARCOMAS; MARKER; TARGET;
D O I：
10.4161/onci.28132
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Most of the studies on cancer/testis (CT) antigens performed to date have focused on their potential value as targets for immunotherapy. Several recent studies, however, revealed that CT antigens might represent useful tools for diagnostic pathology, in particular for the identification of squamous cell carcinoma and related pre-malignant lesions, as well as specific types of sarcoma.
引用
收藏
页数：2
相关论文
共 9 条
  • [1] Cancer/testis (CT) antigens: Potential targets for immunotherapy
    Caballero, Otavia L.
    Chen, Yao-Tseng
    [J]. CANCER SCIENCE, 2009, 100 (11): : 2014 - 2021
  • [2] Chen YTPN, CANC IMMUNO IN PRESS
  • [3] NY-ESO-1 is a sensitive and specific immunohistochemical marker for myxoid and round cell liposarcomas among related mesenchymal myxoid neoplasms
    Hemminger, Jessica A.
    Iwenofu, O. Hans
    [J]. MODERN PATHOLOGY, 2013, 26 (09) : 1204 - 1210
  • [4] The cancer-testis antigen NY-ESO-1 is highly expressed in myxoid and round cell subset of liposarcomas
    Hemminger, Jessica A.
    Toland, Amanda Ewart
    Scharschmidt, Thomas J.
    Mayerson, Joel L.
    Kraybill, William G.
    Guttridge, Denis C.
    Iwenofu, O. Hans
    [J]. MODERN PATHOLOGY, 2013, 26 (02) : 282 - 288
  • [5] Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7
    Jungbluth, AA
    Antonescu, CR
    Busam, KJ
    Iversen, K
    Kolb, D
    Coplan, D
    Chen, YT
    Stockert, E
    Ladanyi, M
    Old, LJ
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2001, 94 (02) : 252 - 256
  • [6] NY-ESO-1 expression in sarcomas A diagnostic marker and immunotherapy target
    Lai, Jin-Ping
    Rosenberg, Avi Z.
    Miettinen, Markku M.
    Lee, Chyi-Chia R.
    [J]. ONCOIMMUNOLOGY, 2012, 1 (08): : 1409 - 1410
  • [7] NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis
    Lai, Jin-Ping
    Robbins, Paul F.
    Raffeld, Mark
    Aung, Phyu Phyu
    Tsokos, Maria
    Rosenberg, Steven A.
    Miettinen, Markku M.
    Lee, Chyi-Chia Richard
    [J]. MODERN PATHOLOGY, 2012, 25 (06) : 854 - 858
  • [8] Expression of cancer/testis (CT) antigens in squamous cell carcinoma of the head and neck: Evaluation as markers of squamous dysplasia
    Piotti, Kathryn C.
    Scognamiglio, Theresa
    Chiu, Rita
    Chen, Yao-Tseng
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2013, 209 (11) : 721 - 726
  • [9] NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma
    Pollack, Seth M.
    Jungbluth, Achim A.
    Hoch, Benjamin L.
    Farrar, Erik A.
    Bleakley, Marie
    Schneider, David J.
    Loggers, Elizabeth T.
    Rodler, Eve
    Eary, Janet F.
    Conrad, Ernest U., III
    Jones, Robin L.
    Yee, Cassian
    [J]. CANCER, 2012, 118 (18) : 4564 - 4570
1